We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$24.5B
AUM Growth
+$1.31B
Cap. Flow
+$569M
Cap. Flow %
2.32%
Top 10 Hldgs %
15.71%
Holding
3,091
New
800
Increased
1,401
Reduced
859
Closed
15

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$23.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$21M
3
MSFT icon
Microsoft
MSFT
+$20.5M
4
DOW icon
Dow Inc
DOW
+$20.2M
5
JPM icon
JPMorgan Chase
JPM
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Financials 16.83%
3 Healthcare 12.9%
4 Consumer Discretionary 10.27%
5 Communication Services 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGB
2876
Trekor Metals
TGB
$2.45B
$4K ﹤0.01%
+7,634
New +$4.41K
TTSH
2877
DELISTED
Tile Shop Holdings
TTSH
$4K ﹤0.01%
889
-12,171
-93% -$57.8K
ASTH icon
2878
Astrana Health
ASTH
$1.81B
$4K ﹤0.01%
+255
New +$4.63K
VSA
2879
VisionSys AI
VSA
$8.3M
$4K ﹤0.01%
+1
New +$10.2K
SIEN
2880
DELISTED
Sientra, Inc.
SIEN
$4K ﹤0.01%
+70
New +$5.04K
FCRD
2881
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$4K ﹤0.01%
+624
New +$4.17K
ASNA
2882
DELISTED
Ascena Retail Group, Inc.
ASNA
$4K ﹤0.01%
329
-2,448
-88% -$51.9K
WFT
2883
DELISTED
Weatherford International plc
WFT
$4K ﹤0.01%
77,442
-57,112
-42% -$32.4K
ABUS icon
2884
Arbutus Biopharma
ABUS
$847M
$3K ﹤0.01%
+1,234
New +$3.16K
BNED icon
2885
Barnes & Noble Education
BNED
$435M
$3K ﹤0.01%
+7
New +$2.69K
DXLG icon
2886
Destination XL Group
DXLG
$32.9M
$3K ﹤0.01%
+1,810
New +$3.51K
ELSE icon
2887
Electro-Sensors
ELSE
$27.3M
$3K ﹤0.01%
+779
New +$2.73K
FRPH icon
2888
FRP Holdings
FRPH
$439M
$3K ﹤0.01%
+96
New +$2.37K
FSTR icon
2889
Foster
FSTR
$421M
$3K ﹤0.01%
+102
New +$2.33K
IDT icon
2890
IDT Corp
IDT
$1.67B
$3K ﹤0.01%
+322
New +$2.37K
MCRB icon
2891
Seres Therapeutics
MCRB
$45M
$3K ﹤0.01%
+43
New +$4.08K
MDGL icon
2892
Madrigal Pharmaceuticals
MDGL
$12.6B
$3K ﹤0.01%
+26
New +$2.79K
OPCH icon
2893
Option Care Health
OPCH
$3.58B
$3K ﹤0.01%
+328
New +$2.68K
SJT
2894
San Juan Basin Royalty Trust
SJT
$119M
$3K ﹤0.01%
+709
New +$3.14K
SLP icon
2895
Simulations Plus
SLP
$371M
$3K ﹤0.01%
+91
New +$2.21K
TMQ
2896
Trilogy Metals
TMQ
$504M
$3K ﹤0.01%
+1,039
New +$2.75K
ULH icon
2897
Universal Logistics Holdings
ULH
$388M
$3K ﹤0.01%
+132
New +$2.82K
URGN icon
2898
UroGen Pharma
URGN
$1.97B
$3K ﹤0.01%
+91
New +$3.35K
WLYB icon
2899
John Wiley & Sons Class B
WLYB
$2.63B
$3K ﹤0.01%
+62
New +$2.81K
ENZ
2900
DELISTED
Enzo Biochem, Inc.
ENZ
$3K ﹤0.01%
+828
New +$2.92K

Similar funds

Aperio Group's Q2 2019 Portfolio in Review

As of Q2 2019, Aperio Group held 3,091 positions worth $24.5B, up 5.7% from $23.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q2 2019 filing shows 800 new, 1,401 increased, 859 reduced and 15 closed positions. Its largest new stake was Dow Inc: 383,303 shares worth $18.9M. The largest sale was American National Group, Inc. Common Stock, an estimated $36.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q2 2019 buy was Dow Inc: 383,303 shares worth $18.9M.
  • Aperio Group added most to AT&T in Q2 2019, an estimated $23.2M increase.
  • Aperio Group's biggest Q2 2019 reduction was American National Group, Inc. Common Stock, cutting an estimated $36.1M.
  • Aperio Group fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $6.06M.
  • Aperio Group's ten largest holdings make up 16% of its $24.5B portfolio in Q2 2019.
  • Aperio Group opened 800 new positions and closed 15 in Q2 2019.
  • Aperio Group's portfolio value rose 5.7% quarter-over-quarter to $24.5B.

Based on Aperio Group's 13F filing for Q2 2019, filed 30 Jul 2019.